Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Colorcon
McKesson
Moodys
Johnson and Johnson
Medtronic
Express Scripts

Last Updated: October 20, 2019

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR DOCETAXEL

See Plans and Pricing

« Back to Dashboard

Clinical Trials for Docetaxel

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00002544 Mitoxantrone With or Without Docetaxel in Treating Women With Metastatic Breast Cancer Completed Arbeitsgemeinschaft fur Internistische Onkologie Phase 3 1993-05-01 RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. It is not yet known if mitoxantrone is more effective with or without docetaxel. PURPOSE: Randomized phase III trial to compare the effectiveness of mitoxantrone with or without docetaxel in treating women who have metastatic breast cancer with a poor prognosis.
NCT00002662 Paclitaxel or Docetaxel in Treating Women With Advanced Breast Cancer Completed Aventis Pharmaceuticals Phase 3 1994-08-01 RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. It is not yet known whether paclitaxel is more effective than docetaxel for breast cancer. PURPOSE: Randomized phase III trial to study the effectiveness of paclitaxel or docetaxel in treating women with stage IIIB or metastatic breast cancer.
NCT00002707 Chemotherapy in Treating Women With Breast Cancer That Can Be Surgically Removed Completed National Cancer Institute (NCI) Phase 3 1995-12-01 RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. It is not yet known if chemotherapy given before surgery is more effective with or without docetaxel given before or after surgery for breast cancer. PURPOSE: Randomized phase III trial to compare the effectiveness of chemotherapy using doxorubicin and cyclophosphamide with or without docetaxel in treating women who have stage II or stage III breast cancer.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for Docetaxel

Condition Name

Condition Name for Docetaxel
Intervention Trials
Breast Cancer 324
Prostate Cancer 245
Non-small Cell Lung Cancer 109
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Condition MeSH for Docetaxel
Intervention Trials
Breast Neoplasms 461
Prostatic Neoplasms 416
Carcinoma, Non-Small-Cell Lung 408
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Locations for Docetaxel

Trials by Country

Trials by Country for Docetaxel
Location Trials
Russian Federation 96
Poland 96
Netherlands 94
Hungary 84
Greece 83
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Trials by US State

Trials by US State for Docetaxel
Location Trials
California 311
Texas 299
New York 295
Ohio 240
Florida 239
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for Docetaxel

Clinical Trial Phase

Clinical Trial Phase for Docetaxel
Clinical Trial Phase Trials
Phase 4 39
Phase 3 357
Phase 2/Phase 3 54
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Clinical Trial Status for Docetaxel
Clinical Trial Phase Trials
Completed 876
Recruiting 332
Terminated 207
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for Docetaxel

Sponsor Name

Sponsor Name for Docetaxel
Sponsor Trials
National Cancer Institute (NCI) 313
Sanofi 195
Hoffmann-La Roche 71
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Sponsor Type for Docetaxel
Sponsor Trials
Other 1935
Industry 1114
NIH 316
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Dow
McKinsey
McKesson
Johnson and Johnson
Moodys
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.